These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11764701)

  • 1. [Rofecoxib].
    Cárdenas E; Barasoain A; Honorato J
    Rev Med Univ Navarra; 2001; 45(2):60-3. PubMed ID: 11764701
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical pharmacology of selective inhibitors of cyclooxygenase-2].
    Patrignani P
    Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):13-8, 37-40. PubMed ID: 15058604
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug safety. Withdrawal of Vioxx casts a shadow over COX-2 inhibitors.
    Couzin J
    Science; 2004 Oct; 306(5695):384-5. PubMed ID: 15486258
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.
    Weir MR; Sperling RS; Reicin A; Gertz BJ
    Am Heart J; 2003 Oct; 146(4):591-604. PubMed ID: 14564311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of inducible nitric oxide synthase and cyclooxygenase-2 inhibitors in formalin-induced nociception in mice.
    Dudhgaonkar SP; Kumar D; Naik A; Devi AR; Bawankule DU; Tandan SK
    Eur J Pharmacol; 2004 May; 492(2-3):117-22. PubMed ID: 15178354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rofecoxib: an update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects.
    Ahuja N; Singh A; Singh B
    J Pharm Pharmacol; 2003 Jul; 55(7):859-94. PubMed ID: 12906745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomedicine. Back to an aspirin a day?
    Vane JR
    Science; 2002 Apr; 296(5567):474-5. PubMed ID: 11964462
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension.
    Hermann M; Camici G; Fratton A; Hurlimann D; Tanner FC; Hellermann JP; Fiedler M; Thiery J; Neidhart M; Gay RE; Gay S; Lüscher TF; Ruschitzka F
    Circulation; 2003 Nov; 108(19):2308-11. PubMed ID: 14597594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comment on efficacy of rofecoxib and nimesulide in controlling post-extraction pain in oral surgery: a randomised comparative study.
    Villa G
    Curr Med Res Opin; 2004 Apr; 20(4):573-4; author reply 574. PubMed ID: 15119995
    [No Abstract]   [Full Text] [Related]  

  • 10. [Meta-analysis on acute pain. Rofecoxib helped three quarters of patients].
    MMW Fortschr Med; 2003 Aug; 145(31-32):57. PubMed ID: 14524084
    [No Abstract]   [Full Text] [Related]  

  • 11. Rofecoxib interaction with oral anticoagulant acenocoumarol.
    Girardin F; Siegenthaler M; De Moerloose P; Desmeules J
    Eur J Clin Pharmacol; 2003 Sep; 59(5-6):489-90. PubMed ID: 12898082
    [No Abstract]   [Full Text] [Related]  

  • 12. [Selective COX-2 inhibitors--strong medicine for pain].
    MMW Fortschr Med; 2004 Apr; 146(17):56-7. PubMed ID: 15224910
    [No Abstract]   [Full Text] [Related]  

  • 13. An update on specific COX-2 inhibitors: the COXIBs.
    Gupta S; Crofford LJ
    Bull Rheum Dis; 2001; 50(1):1-4. PubMed ID: 12092091
    [No Abstract]   [Full Text] [Related]  

  • 14. [Selective COX 2 inhibitor rofecoxib. To "defy" the pain].
    MMW Fortschr Med; 2003 Aug; 145(31-32):56-7. PubMed ID: 14524083
    [No Abstract]   [Full Text] [Related]  

  • 15. [General practice study of therapy of acute pain. Patients prefer cox-2 inhibitors].
    MMW Fortschr Med; 2004 May; 146(21):61. PubMed ID: 15373091
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical profiles of celecoxib and rofecoxib in the rheumatic diseases.
    Gibofsky A
    J Hypertens Suppl; 2002 Sep; 20(6):S25-30. PubMed ID: 12683424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient empowerment: rofecoxib revisited.
    Tannenbaum H
    J Rheumatol; 2006 Jun; 33(6):1033-5. PubMed ID: 16755647
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study.
    Bogaty P; Brophy JM; Noel M; Boyer L; Simard S; Bertrand F; Dagenais GR
    Circulation; 2004 Aug; 110(8):934-9. PubMed ID: 15302800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effective not only in rheumatism and arthrosis. Rofecoxib fights also acute pain].
    MMW Fortschr Med; 2002 Feb; 144(7):68. PubMed ID: 11887740
    [No Abstract]   [Full Text] [Related]  

  • 20. [New indication for selective COX-2 inhibitors. Now also approve for acute pain].
    MMW Fortschr Med; 2002 Mar; 144(10):62. PubMed ID: 11928272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.